Top Key Companies for Veterinary CRO and CDMO Market: Argenta Group (Klifovet), Charles River Laboratories, Clinvet, IDEXX Laboratories, Inotiv, Knoell – Triveritas, Labcorp Drug Development, Oncovet Clinical Research (OCR), Veterinary Research Management, Vetio, VETSPIN, Zoetis-Nexvet.
Global Veterinary CRO and CDMO Market Size was estimated at USD 6130.03 million in 2022 and is projected to reach USD 10800.62 million by 2028, exhibiting a CAGR of 9.9% during the forecast period.
Global Veterinary CRO and CDMO Market Overview And Scope:
The Global Veterinary CRO and CDMO Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Veterinary CRO and CDMO utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Veterinary CRO and CDMO Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary CRO and CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary CRO and CDMO market.
Global Veterinary CRO and CDMO Market Segmentation
By Type, Veterinary CRO and CDMO market has been segmented into:
Contract Development &Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)
By Application, Veterinary CRO and CDMO market has been segmented into:
Medicines
Medical Devices
Regional Analysis of Veterinary CRO and CDMO Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Veterinary CRO and CDMO Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Veterinary CRO and CDMO market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Veterinary CRO and CDMO market.
Top Key Companies Covered in Veterinary CRO and CDMO market are:
Argenta Group (Klifovet)
Charles River Laboratories
Clinvet
IDEXX Laboratories
Inotiv
Knoell – Triveritas
Labcorp Drug Development
Oncovet Clinical Research (OCR)
Veterinary Research Management
Vetio
VETSPIN
Zoetis-Nexvet
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Veterinary CRO and CDMO Market by Type
5.1 Veterinary CRO and CDMO Market Overview Snapshot and Growth Engine
5.2 Veterinary CRO and CDMO Market Overview
5.3 Contract Development &Manufacturing Organizations (CDMO)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Contract Development &Manufacturing Organizations (CDMO): Geographic Segmentation
5.4 Contract Research Organizations (CRO)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Contract Research Organizations (CRO): Geographic Segmentation
Chapter 6: Veterinary CRO and CDMO Market by Application
6.1 Veterinary CRO and CDMO Market Overview Snapshot and Growth Engine
6.2 Veterinary CRO and CDMO Market Overview
6.3 Medicines
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Medicines: Geographic Segmentation
6.4 Medical Devices
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Medical Devices: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Veterinary CRO and CDMO Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Veterinary CRO and CDMO Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Veterinary CRO and CDMO Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ARGENTA GROUP (KLIFOVET)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CHARLES RIVER LABORATORIES
7.4 CLINVET
7.5 IDEXX LABORATORIES
7.6 INOTIV
7.7 KNOELL – TRIVERITAS
7.8 LABCORP DRUG DEVELOPMENT
7.9 ONCOVET CLINICAL RESEARCH (OCR)
7.10 VETERINARY RESEARCH MANAGEMENT
7.11 VETIO
7.12 VETSPIN
7.13 ZOETIS-NEXVET
Chapter 8: Global Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Contract Development &Manufacturing Organizations (CDMO)
8.2.2 Contract Research Organizations (CRO)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Medicines
8.3.2 Medical Devices
Chapter 9: North America Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Contract Development &Manufacturing Organizations (CDMO)
9.4.2 Contract Research Organizations (CRO)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Medicines
9.5.2 Medical Devices
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Contract Development &Manufacturing Organizations (CDMO)
10.4.2 Contract Research Organizations (CRO)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Medicines
10.5.2 Medical Devices
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Contract Development &Manufacturing Organizations (CDMO)
11.4.2 Contract Research Organizations (CRO)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Medicines
11.5.2 Medical Devices
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Contract Development &Manufacturing Organizations (CDMO)
12.4.2 Contract Research Organizations (CRO)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Medicines
12.5.2 Medical Devices
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Contract Development &Manufacturing Organizations (CDMO)
13.4.2 Contract Research Organizations (CRO)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Medicines
13.5.2 Medical Devices
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Veterinary CRO and CDMO Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Contract Development &Manufacturing Organizations (CDMO)
14.4.2 Contract Research Organizations (CRO)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Medicines
14.5.2 Medical Devices
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Veterinary CRO and CDMO Scope:
|
Report Data
|
Veterinary CRO and CDMO Market
|
|
Veterinary CRO and CDMO Market Size in 2025
|
USD XX million
|
|
Veterinary CRO and CDMO CAGR 2025 - 2032
|
XX%
|
|
Veterinary CRO and CDMO Base Year
|
2024
|
|
Veterinary CRO and CDMO Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Argenta Group (Klifovet), Charles River Laboratories, Clinvet, IDEXX Laboratories, Inotiv, Knoell – Triveritas, Labcorp Drug Development, Oncovet Clinical Research (OCR), Veterinary Research Management, Vetio, VETSPIN, Zoetis-Nexvet.
|
|
Key Segments
|
By Type
Contract Development &Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)
By Applications
Medicines
Medical Devices
|
